{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:58:49Z","timestamp":1789966729065,"version":"4.0.1"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Health and Medical Research Council of Australia","award":["1113842"],"award-info":[{"award-number":["1113842"]}]},{"DOI":"10.13039\/501100001061","name":"Rebecca L Cooper Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001061","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.canlet.2016.03.047","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T09:34:14Z","timestamp":1459676054000},"page":"106-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Hepatocellular carcinoma: Mouse models and the potential roles of proteases"],"prefix":"10.1016","volume":"387","author":[{"given":"James M.","family":"Henderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Emma","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-2604","authenticated-orcid":false,"given":"Mark D.","family":"Gorrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2016.03.047_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.canlet.2016.03.047_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.canlet.2016.03.047_bib0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21161","article-title":"Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma","volume":"62","author":"Maluccio","year":"2012","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.canlet.2016.03.047_bib0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2036.2009.04200.x","article-title":"Review article: the management of hepatocellular carcinoma","volume":"31","author":"Cabrera","year":"2010","journal-title":"Aliment. Pharmacol. Ther"},{"key":"10.1016\/j.canlet.2016.03.047_bib0030","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1111\/j.1872-034X.2007.00168.x","article-title":"Epidemiology of hepatocellular carcinoma in USA","volume":"37","author":"El-Serag","year":"2007","journal-title":"Hepatol. Res"},{"key":"10.1016\/j.canlet.2016.03.047_bib0035","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1053\/jhep.2002.36366","article-title":"Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China","volume":"36","author":"Ming","year":"2002","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.canlet.2016.03.047_bib0040","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1111\/j.1075-122X.2006.00205.x","article-title":"Use of statistics to assess the global burden of breast cancer","volume":"12","author":"Parkin","year":"2006","journal-title":"Breast J."},{"key":"10.1016\/j.canlet.2016.03.047_bib0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/35094059","article-title":"Putting tumours in context","volume":"1","author":"Bissell","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2016.03.047_bib0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc2067","article-title":"The tumour microenvironment as a target for chemoprevention","volume":"7","author":"Albini","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2016.03.047_bib0055","first-page":"1733","article-title":"The tumor microenvironment in hepatocellular carcinoma","volume":"40","author":"Leonardi","year":"2012","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semcancer.2010.10.007","article-title":"The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets","volume":"21","author":"Yang","year":"2011","journal-title":"Semin. Cancer Biol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0065","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2016.03.047_bib0070","first-page":"189","article-title":"Ultrastructural features of wound healing in mouse skin","volume":"105","author":"Tarin","year":"1969","journal-title":"J. Anat"},{"key":"10.1016\/j.canlet.2016.03.047_bib0075","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","article-title":"Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers","volume":"87","author":"Garin-Chesa","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.03.047_bib0080","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrc1477","article-title":"Friends or foes\u2014bipolar effects of the tumour stroma in cancer","volume":"4","author":"Mueller","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2016.03.047_bib0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1073\/pnas.87.1.75","article-title":"Fibroblast-mediated acceleration of human epithelial tumor growth in vivo","volume":"87","author":"Camps","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.03.047_bib0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2004.10.017","article-title":"Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development","volume":"92","author":"Cunha","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0095","first-page":"5002","article-title":"Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium","volume":"59","author":"Olumi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.03.047_bib0100","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/ncb1658","article-title":"Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells","volume":"9","author":"Gaggioli","year":"2007","journal-title":"Nat. Cell Biol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.canlet.2016.03.047_bib0110","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.82.24.8681","article-title":"Hepatic lipocytes: the principal collagen-producing cells of normal rat liver","volume":"82","author":"Friedman","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.03.047_bib0115","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.5858\/2007-131-1728-HSCALF","article-title":"Hepatic stellate cells and liver fibrosis","volume":"131","author":"Moreira","year":"2007","journal-title":"Arch. Pathol. Lab. Med"},{"key":"10.1016\/j.canlet.2016.03.047_bib0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0168-8278(99)80074-9","article-title":"Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study","volume":"30","author":"Faouzi","year":"1999","journal-title":"J. Hepatol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ctrv.2011.06.010","article-title":"Role of the microenvironment in hepatocellular carcinoma development and progression","volume":"38","author":"Wu","year":"2012","journal-title":"Cancer Treat. Rev"},{"key":"10.1016\/j.canlet.2016.03.047_bib0130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3892\/or.2013.2872","article-title":"Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling","volume":"31","author":"Han","year":"2014","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.canlet.2016.03.047_bib0135","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2014.10.029","article-title":"Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma","volume":"62","author":"Yeung","year":"2015","journal-title":"J. Hepatol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0145","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1158\/0008-5472.CAN-09-0901","article-title":"Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1\/programmed death-1 interactions","volume":"69","author":"Wu","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.03.047_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hemonc.2013.09.005","article-title":"The immunoinhibitory B7-H1 molecule as a potential target in cancer: killing many birds with one stone","volume":"7","author":"Afreen","year":"2014","journal-title":"Hematol. Oncol. Stem Cell Ther"},{"key":"10.1016\/j.canlet.2016.03.047_bib0155","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nrc2228","article-title":"Emerging roles of proteases in tumour suppression","volume":"7","author":"L\u00f3pez-Otin","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2016.03.047_bib0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0009-8981(99)00224-7","article-title":"Unraveling the role of proteases in cancer","volume":"291","author":"Koblinski","year":"2000","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.canlet.2016.03.047_bib0165","first-page":"237","article-title":"Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma","volume":"17","author":"Sakamoto","year":"2000","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0170","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4161\/cbt.5.7.2754","article-title":"CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients","volume":"5","author":"Zhang","year":"2006","journal-title":"Cancer Biol. Ther"},{"key":"10.1016\/j.canlet.2016.03.047_bib0175","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1369\/jhc.2009.953760","article-title":"The in vivo expression of dipeptidyl peptidases 8 and 9","volume":"57","author":"Yu","year":"2009","journal-title":"J. Histochem. Cytochem"},{"key":"10.1016\/j.canlet.2016.03.047_bib0180","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00395-013-0350-4","article-title":"Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis","volume":"108","author":"Matheeussen","year":"2013","journal-title":"Basic Res. Cardiol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0185","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10753-015-0263-5","article-title":"The dipeptidyl peptidases 4, 8, and 9 in mouse monocytes and macrophages: DPP8\/9 inhibition attenuates M1 macrophage activation in mice","volume":"39","author":"Waumans","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.canlet.2016.03.047_bib0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1515\/CCLM.2009.085","article-title":"Dipeptidyl peptidases and related proteins: multifaceted markers and therapeutic targets","volume":"47","author":"De Meester","year":"2009","journal-title":"Clin. Chem. Lab. Med"},{"key":"10.1016\/j.canlet.2016.03.047_bib0195","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.4049\/jimmunol.1202583","article-title":"Dipeptidyl peptidase IV is a human and murine neutrophil chemorepellent","volume":"190","author":"Herlihy","year":"2013","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2337\/db12-0230","article-title":"A potential role for dendritic cell\/macrophage-expressing DPP4 in obesity-induced visceral inflammation","volume":"62","author":"Zhong","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.canlet.2016.03.047_bib0205","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.4049\/jimmunol.1103801","article-title":"Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26)","volume":"188","author":"Bengsch","year":"2012","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0210","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1515\/bchm3.1990.371.2.699","article-title":"Dipeptidyl peptidase IV in the immune system. Cytofluorometric evidence for induction of the enzyme on activated T lymphocytes","volume":"371","author":"Sch\u00f6n","year":"1990","journal-title":"Biol. Chem. Hoppe. Seyler"},{"key":"10.1016\/j.canlet.2016.03.047_bib0215","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1535-7163.MCT-11-0340","article-title":"Rationale behind targeting fibroblast activation protein\u2013expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy","volume":"11","author":"Brennen","year":"2012","journal-title":"Mol. Cancer Therapeut"},{"key":"10.1016\/j.canlet.2016.03.047_bib0220","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.3748\/wjg.v19.i19.2883","article-title":"Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver","volume":"19","author":"Chowdhury","year":"2013","journal-title":"World J. Gastroenterol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0225","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/hep.20853","article-title":"Fibroblast activation protein increases apoptosis, cell adhesion and migration by the LX-2 human stellate cell line","volume":"42","author":"Wang","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2016.03.047_bib0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.regpep.2013.07.003","article-title":"DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues","volume":"186","author":"Harstad","year":"2013","journal-title":"Regul. Pept"},{"key":"10.1016\/j.canlet.2016.03.047_bib0235","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.1840110403","article-title":"Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence","volume":"11","author":"McCaughan","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2016.03.047_bib0240","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0168-8278(97)80180-8","article-title":"Aberrant dipeptidyl peptidase IV (DPP IV\/CD26) expression in human hepatocellular carcinoma","volume":"27","author":"Stecca","year":"1997","journal-title":"J. Hepatol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0245","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1742-4658.2009.07526.x","article-title":"The Dipeptidyl Peptidase IV family in cancer and cell biology","volume":"277","author":"Yu","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.canlet.2016.03.047_bib0250","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fob.2013.12.001","article-title":"Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs","volume":"4","author":"Keane","year":"2014","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.canlet.2016.03.047_bib0255","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/1753-0407.12237","article-title":"Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study","volume":"7","author":"Williams","year":"2015","journal-title":"J. Diabetes"},{"key":"10.1016\/j.canlet.2016.03.047_bib0260","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.diabres.2015.02.024","article-title":"Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity","volume":"108","author":"Williams","year":"2015","journal-title":"Diabetes Res. Clin. Pract"},{"key":"10.1016\/j.canlet.2016.03.047_bib0265","series-title":"Proteinases as Drug Targets","first-page":"119","article-title":"Targeting Dipeptidyl Peptidase-4 (DPP-4) and Fibroblast Activation Protein (FAP) for diabetes and cancer therapy","author":"Keane","year":"2012"},{"key":"10.1016\/j.canlet.2016.03.047_bib0270","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humpath.2005.11.020","article-title":"Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis","volume":"37","author":"Acharya","year":"2006","journal-title":"Hum. Pathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0275","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MPA.0b013e31816618ce","article-title":"Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma","volume":"37","author":"Cohen","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.canlet.2016.03.047_bib0280","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/01913120802034934","article-title":"FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions","volume":"32","author":"Goscinski","year":"2008","journal-title":"Ultrastruct. Pathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0285","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1158\/1078-0432.CCR-06-1746","article-title":"Clinical implications of fibroblast activation protein in patients with colon cancer","volume":"13","author":"Henry","year":"2007","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.03.047_bib0290","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1073\/pnas.91.12.5657","article-title":"Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers","volume":"91","author":"Scanlan","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.03.047_bib0295","article-title":"Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.03.047_bib0300","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.humpath.2013.06.016","article-title":"Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer","volume":"44","author":"Tchou","year":"2013","journal-title":"Hum. Pathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0305","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1158\/2326-6066.CIR-13-0150","article-title":"Tumoral Immune Suppression by Macrophages Expressing Fibroblast Activation Protein and Heme Oxygenase-1","volume":"2","author":"Arnold","year":"2014","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.canlet.2016.03.047_bib0310","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.510290631","article-title":"Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis","volume":"29","author":"Levy","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2016.03.047_bib0315","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1034\/j.1600-0676.2002.01503.x","article-title":"Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection","volume":"22","author":"Levy","year":"2002","journal-title":"Liver Internat"},{"key":"10.1016\/j.canlet.2016.03.047_bib0320","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/CS20040302","article-title":"Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders","volume":"108","author":"Gorrell","year":"2005","journal-title":"Clin. Sci"},{"key":"10.1016\/j.canlet.2016.03.047_bib0325","first-page":"1345","article-title":"CD26\/dipeptidyl peptidase IV and its role in cancer","volume":"19","author":"Pro","year":"2004","journal-title":"Histol. Histopathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0330","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1146\/annurev.immunol.22.012703.104543","article-title":"Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells","volume":"22","author":"Rot","year":"2004","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0335","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1084\/jem.186.11.1865","article-title":"Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation normal T cell expressed and activated) by dipeptidyl peptidase IV (CD26)-mediated cleavage","volume":"186","author":"Oravecz","year":"1997","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.canlet.2016.03.047_bib0340","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ijc.28393","article-title":"Evidence for the antagonistic form of CXC-motif chemokine CXCL10 in serous epithelial ovarian tumours","volume":"134","author":"Rainczuk","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2016.03.047_bib0345","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3892\/ol.2011.300","article-title":"The emerging role of CXCL10 in cancer","volume":"2","author":"Liu","year":"2011","journal-title":"Oncol. Lett"},{"key":"10.1016\/j.canlet.2016.03.047_bib0350","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/ni.3201","article-title":"Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy","volume":"16","author":"Barreira da Silva","year":"2015","journal-title":"Nature Immunol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0355","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cca.2013.04.026","article-title":"Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma","volume":"423","author":"Chen","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.canlet.2016.03.047_bib0360","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/pmic.200600654","article-title":"The Simpson\u2013Golabi\u2013Behmel syndrome causative Glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26","volume":"7","author":"Davoodi","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.canlet.2016.03.047_bib0365","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/j.1939-4640.2000.tb02099.x","article-title":"Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands","volume":"21","author":"Wilson","year":"2000","journal-title":"J. Androl"},{"key":"10.1016\/j.canlet.2016.03.047_bib0370","first-page":"677","article-title":"Suppression of lung metastases by the CD26\/DPP4 inhibitor Vildagliptin in mice","volume":"32","author":"Jang","year":"2015","journal-title":"Clin. Exp. Immunol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0375","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1111\/bph.13274","article-title":"Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression","volume":"172","author":"Choi","year":"2015","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0380","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3892\/or.2015.4429","article-title":"The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice","volume":"35","author":"Yorifuji","year":"2016","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.canlet.2016.03.047_bib0385","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3892\/ijo.2012.1522","article-title":"Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines","volume":"41","author":"Wilson","year":"2012","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0390","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbaexp.2004.03.010","article-title":"Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity","volume":"1679","author":"Ajami","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2016.03.047_bib0395","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1111\/j.1742-4658.2006.05253.x","article-title":"Extra-enzymatic functions of the dipeptidyl peptidase (DP) IV related proteins DP8 and DP9 in cell adhesion, migration and apoptosis","volume":"273","author":"Yu","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.canlet.2016.03.047_bib0400","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/1541-7786.MCR-10-0272","article-title":"A Novel Role of Dipeptidyl Peptidase 9 in Epidermal Growth Factor Signaling","volume":"9","author":"Yao","year":"2011","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.canlet.2016.03.047_bib0405","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.bbamcr.2014.11.029","article-title":"Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin","volume":"1853","author":"Zhang","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2016.03.047_bib0410","doi-asserted-by":"crossref","first-page":"27494","DOI":"10.1074\/jbc.M111.224089","article-title":"Dipeptidyl Peptidases as Survival Factors in Ewing Sarcoma Family of Tumors: Implications for tumor biology and therapy","volume":"286","author":"Lu","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2016.03.047_bib0415","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/leu.2013.9","article-title":"Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide's anti-leukemic activity","volume":"27","author":"Spagnuolo","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2016.03.047_bib0420","doi-asserted-by":"crossref","first-page":"27211","DOI":"10.1074\/jbc.M109.041871","article-title":"The cytoplasmic peptidase DPP9 Is rate-limiting for degradation of proline-containing peptides","volume":"284","author":"Geiss-Friedlander","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2016.03.047_bib0425","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1158\/1541-7786.MCR-13-0272","article-title":"Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9","volume":"11","author":"Zhang","year":"2013","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.canlet.2016.03.047_bib0430","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fimmu.2015.00387","article-title":"The Dipeptidyl Peptidase family, Prolyl Oligopeptidase and Prolyl Carboxypeptidase in the immune system and inflammatory disease, including Atherosclerosis","volume":"6","author":"Waumans","year":"2015","journal-title":"Front. Immunol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0435","doi-asserted-by":"crossref","DOI":"10.1111\/cei.12757","article-title":"Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and\/or structure homolog (DASH) proteins","author":"Wagner","year":"2016","journal-title":"Clin. Exp. Immunol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0440","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.2337\/diabetes.54.10.2988","article-title":"Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes - Potential importance of selectivity over dipeptidyl peptidases 8 and 9","volume":"54","author":"Lankas","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.canlet.2016.03.047_bib0445","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1369\/jhc.7A7319.2007","article-title":"Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8\/9, and DP10 in allergic responses of the lung in rats","volume":"56","author":"Schade","year":"2008","journal-title":"J. Histochem. Cytochem"},{"key":"10.1016\/j.canlet.2016.03.047_bib0450","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1111\/febs.13371","article-title":"Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis","volume":"282","author":"Zhang","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.canlet.2016.03.047_bib0455","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yexcr.2016.02.020","article-title":"Dipeptidyl peptidase 9 enzymatic activity influences the expression of neonatal metabolic genes","volume":"342","author":"Chen","year":"2016","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.canlet.2016.03.047_bib0460","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1073\/pnas.0603499103","article-title":"Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation","volume":"103","author":"Sakurai","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.03.047_bib0465","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2016.03.047_bib0470","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/01926230252824770","article-title":"Quantitation of the cancer process in C57BL\/6J, B6C3F1 and C3H\/HeJ mice","volume":"30","author":"Goldsworthy","year":"2002","journal-title":"Toxicol. Pathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0475","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00432-007-0336-4","article-title":"Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis","volume":"134","author":"Zimmers","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0480","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/carcin\/7.2.215","article-title":"Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL\/6NCr, C3H\/HeNCrMTV- and DBA\/2NCr mice","volume":"7","author":"Diwan","year":"1986","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2016.03.047_bib0485","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/hep.24133","article-title":"Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice","volume":"53","author":"Aleksic","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2016.03.047_bib0490","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jss.2007.12.748","article-title":"Mouse model of diethylnitrosamine-induced gastric cancer","volume":"148","author":"Binato","year":"2008","journal-title":"J. Surg. Res"},{"key":"10.1016\/j.canlet.2016.03.047_bib0495","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/carcin\/13.8.1491","article-title":"Protection against benzo[a]pyrene- and N-nitrosodiethylamine-induced lung and forestomach tumorigenesis in A\/J mice by water extracts of green tea and licorice","volume":"13","author":"Wang","year":"1992","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2016.03.047_bib0500","first-page":"6470","article-title":"Chronic nitrosamine ingestion in 1040 rodents: the effect of the choice of nitrosamine, the species studied, and the age of starting exposure","volume":"51","author":"Gray","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.03.047_bib0505","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0163-7258(96)00062-9","article-title":"N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation","volume":"71","author":"Verna","year":"1996","journal-title":"Pharmacol. Ther"},{"key":"10.1016\/j.canlet.2016.03.047_bib0510","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/taap.1996.8089","article-title":"Vitamin E modulation of hepatic focal lesion growth in mice","volume":"143","author":"Kolaja","year":"1997","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0515","first-page":"4253","article-title":"Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse","volume":"43","author":"Vesselinovitch","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.03.047_bib0520","first-page":"1625","article-title":"Age- and sex-associated diethylnitrosamine dealkylation activity of the mouse liver and hepatocarcinogenesis","volume":"33","author":"Rao","year":"1973","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.03.047_bib0525","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20768","article-title":"Genotype-phenotype relationships in hepatocellular tumors from mice and man","volume":"42","author":"Stahl","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2016.03.047_bib0530","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/carcin\/14.8.1603","article-title":"Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors","volume":"14","author":"Chen","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2016.03.047_bib0535","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.20375","article-title":"Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling","volume":"40","author":"Lee","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2016.03.047_bib0540","doi-asserted-by":"crossref","DOI":"10.1289\/ehp.77217","article-title":"Carcinogenicity studies on halogenated hydrocarbons","volume":"21","author":"Weisburger","year":"1977","journal-title":"Environ. Health Perspect"},{"key":"10.1016\/j.canlet.2016.03.047_bib0545","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.etp.2014.03.003","article-title":"Establishment of a liver fibrosis model in cynomolgus monkeys","volume":"66","author":"Ding","year":"2014","journal-title":"Exp. Toxicol. Pathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0550","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S0021-9258(19)75686-5","article-title":"Increased procollagen mRNA levels in carbon tetrachloride-induced liver fibrosis in rats","volume":"262","author":"Pierce","year":"1987","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2016.03.047_bib0555","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.1840030118","article-title":"Is cirrhosis of the liver experimentally produced by CCl4 an adequate model of human cirrhosis?","volume":"3","author":"Tamayo","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2016.03.047_bib0560","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/10590500701569398","article-title":"Postulated carbon tetrachloride mode of action: a review","volume":"25","author":"Manibusan","year":"2007","journal-title":"J. Environ. Sci. Health C."},{"key":"10.1016\/j.canlet.2016.03.047_bib0565","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0300-483X(01)00429-2","article-title":"Carbon tetrachloride-induced changes in the activity of phase II drug-metabolizing enzyme in the liver of male rats: role of antioxidants","volume":"165","author":"Sheweita","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.canlet.2016.03.047_bib0570","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0002-9440(10)65594-0","article-title":"Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride","volume":"153","author":"Shi","year":"1998","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0575","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2613.2009.00656.x","article-title":"Experimental mouse models for hepatocellular carcinoma research","volume":"90","author":"Heindryckx","year":"2009","journal-title":"Int. J. Exp. Pathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0580","first-page":"502","article-title":"Instant cirrhosis. An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone","volume":"50","author":"McLean","year":"1969","journal-title":"Br. J. Exp. Pathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0585","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2016.03.047_bib0590","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.03.047_bib0595","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0232-1513(88)80155-5","article-title":"Thioacetamide-induced cirrhosis-like liver lesions in rats\u2013usefulness and reliability of this animal model","volume":"34","author":"Muller","year":"1988","journal-title":"Exp. Pathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0600","first-page":"95","article-title":"Experimental thioacetamide-induced cirrhosis of the liver","volume":"6","author":"Munoz Torres","year":"1991","journal-title":"Histol. Histopathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0605","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-015-1543-4","article-title":"Experimental models of liver fibrosis","author":"Crespo Yanguas","year":"2016","journal-title":"Arch. Toxicol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0610","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-3565(25)30789-5","article-title":"Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system","volume":"200","author":"Hunter","year":"1977","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.canlet.2016.03.047_bib0615","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1021\/tx3002719","article-title":"Metabolism and toxicity of thioacetamide and thioacetamide S-oxide in rat hepatocytes","volume":"25","author":"Hajovsky","year":"2012","journal-title":"Chem. Res. Toxicol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0620","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0300-483X(84)90154-9","article-title":"Role of the microsomal fad-containing monooxygenase in the liver toxicity of thioacetamide S-oxide","volume":"31","author":"Chieli","year":"1984","journal-title":"Toxicology"},{"key":"10.1016\/j.canlet.2016.03.047_bib0625","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1440-1746.2012.07265.x","article-title":"Attenuation of hepatic fibrosis by an imidazolium salt in thioacetamide-induced mouse model","volume":"28","author":"Ding","year":"2013","journal-title":"J. Gastroenterol. Hepatol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0630","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/hep.23435","article-title":"CXC chemokine ligand 4 (CXCL4) is a platelet-derived mediator of experimental liver fibrosis","volume":"51","author":"Zaldivar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2016.03.047_bib0635","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/labinvest.2008.91","article-title":"Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice","volume":"88","author":"Salguero Palacios","year":"2008","journal-title":"Lab. Invest"},{"key":"10.1016\/j.canlet.2016.03.047_bib0640","first-page":"553","article-title":"Thioacetamide hepatocarcinogenesis","volume":"71","author":"Becker","year":"1983","journal-title":"J. Natl Cancer Inst"},{"key":"10.1016\/j.canlet.2016.03.047_bib0645","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000225560","article-title":"Thioacetamide-induced hepatocarcinoma in rat","volume":"38","author":"Dasgupta","year":"1981","journal-title":"Oncology"},{"key":"10.1016\/j.canlet.2016.03.047_bib0650","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/labinvest.2010.139","article-title":"Induction of liver fibrosis in a murine hepatoma model by thioacetamide is associated with enhanced tumor growth and suppressed antitumor immunity","volume":"90","author":"Yang","year":"2010","journal-title":"Lab. Invest"},{"key":"10.1016\/j.canlet.2016.03.047_bib0655","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0232-1513(84)80063-8","article-title":"Histogenesis of cholangiomas and cholangiocarcinomas in thioacetamide fed rats","volume":"26","author":"Praet","year":"1984","journal-title":"Exp. Pathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1007082515548","article-title":"Cholangiocarcinoma and liver cirrhosis in relation to changes due to thioacetamide","volume":"208","author":"Al-Bader","year":"2000","journal-title":"Mol. Cell. Biochem"},{"key":"10.1016\/j.canlet.2016.03.047_bib0665","first-page":"957","article-title":"Correlation between Bcl-2 expression and histopathology in diethylnitrosamine-induced mouse hepatocellular tumors","volume":"151","author":"Lee","year":"1997","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0670","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/carcin\/4.8.1021","article-title":"Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice","volume":"4","author":"Ward","year":"1983","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2016.03.047_bib0675","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3835(84)90157-5","article-title":"Inhibition by phenobarbital and lack of effect of amobarbital on the development of liver tumors induced by N-nitrosodiethylamine in juvenile B6C3F1 mice","volume":"23","author":"Diwan","year":"1984","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2016.03.047_bib0680","first-page":"449","article-title":"Effect of phenobarbital on the development of liver tumors in juvenile and adult mice","volume":"77","author":"Pereira","year":"1986","journal-title":"J. Natl Cancer Inst"},{"key":"10.1016\/j.canlet.2016.03.047_bib0685","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/019262330002800201","article-title":"Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis","volume":"28","author":"Lee","year":"2000","journal-title":"Toxicol. Pathol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0690","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/egh.09.32","article-title":"Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal","volume":"3","author":"Alkhouri","year":"2009","journal-title":"Expert Rev. Gastroenterol. Hepatol"},{"key":"10.1016\/j.canlet.2016.03.047_bib0695","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canlet.2016.03.047_bib0700","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.03.047_bib0705","first-page":"13","article-title":"Contribution of Gut Bacteria to Liver Pathobiology, Gastroenterol","volume":"2010","author":"Son","year":"2010","journal-title":"Res. Prac"},{"key":"10.1016\/j.canlet.2016.03.047_bib0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-014-0195-9","article-title":"High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma","volume":"14","author":"Duan","year":"2014","journal-title":"BMC Gastroenterol"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516302087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516302087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:59:28Z","timestamp":1748833168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383516302087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":141,"alternative-id":["S0304383516302087"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2016.03.047","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocellular carcinoma: Mouse models and the potential roles of proteases","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2016.03.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}